Home
Applications
Indications
Business
EpiSwitch
®
Products
EpiSwitch
®
Checkpoint Inhibitor Response Test
EpiSwitch
®
COVID-19 Severity Test
EpiSwitch
®
Explorer Array Kit
EPISWITCH
®
ANALYTICAL PORTAL
EpiSwitch
®
Service
Investors
Investors Overview
Results and Presentations
Share Price Information
Regulatory News
Board & Governance
Key Corporate Documents
AIM Rule 26
Email Alerts
Investor Contacts
News
About Us
History
Board of Directors
Management Team
Scientific Advisory Panel
Values
Careers
Contact Us
OBD files 4 new and 2 divisional patent applications on the use of the EpiSwitch™ technology in companion diagnostics, biological systems and specific clinical indications, including ALS and PD-1 based cancer immunotherapies.
November 6, 2015
|
In
Milestones
|
By
Aroul Ramadass
Prev
Next
Privacy Preference Center
Privacy Preferences